HK Stock MarketDetailed Quotes

03759 PHARMARON

Watchlist
  • 14.280
  • -0.760-5.05%
Market Closed Dec 13 16:08 CST
25.52BMarket Cap12.22P/E (TTM)

About PHARMARON Company

The company is an internationally leading life science research and development service enterprise. Since its establishment in 2004, Kanglong Chemical has been committed to its talent training and facility construction, and has built an R&D and production service system throughout the entire process of drug discovery, pre-clinical and clinical development for multi-therapy drug research and development, including small molecules, macromolecules, and cell and gene therapy drugs. The company is a leading full-process integrated pharmaceutical research and development service platform. It operates all over the world and is committed to helping customers accelerate drug innovation. Products include small molecule chemicals, large molecule biopharmaceuticals, cell and gene therapy products, etc.

Company Profile

Symbol03759
Company NamePHARMARON
ISINCNE100003PG4
Listing DateNov 28, 2019
Issue Price39.50
Shares Offered116.54M share(s)
FoundedJul 1, 2004
Registered AddressChina
Chairmanbailiang lou
Secretaryluojun yan
Audit InstitutionErnst & Young, Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
Company CategoryOther
Registered Office8th Floor, Building 1, No. 6 Taihe Road, Beijing Economic and Technological Development Zone, Beijing
Head Office and Principal Place of Business40th Floor, Dah Sing Finance Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees20342
MarketHong Kong motherboard
Phone010-57330087
Fax010-57330087
Emailpharmaron@pharmaron.com
Websitehttp://www.pharmaron.cn/
BusinessResearch and development of medicinal compounds, chemicals, biological products, and biotechnology; provision of technical development, technology transfer, technical consulting, technical services, technical training; import and export of goods and technology. (For projects subject to approval according to law, business activities are carried out according to the approved content after approval by the relevant departments.) (Subject to the scope of business approved by the market supervisory and regulatory authority)

Company Executives

  • Name
  • Position
  • Salary
  • bailiang lou
  • Chairman, CEOs, Executive Director, Chairman of the Strategy Committee, Remuneration Committee Members, Nomination Committee Members
  • 2.21M
  • xiaoqiang lou
  • President, Executive Director, Chief Operating Officer, Strategy Committee Members, Remuneration Committee Members, Authorized Representative
  • 1.91M
  • bei zheng
  • Executive Vice President, Executive Director, Nomination Committee Members
  • 1.60M
  • baifeng hu
  • Non-executive Directors, Strategy Committee Members
  • --
  • jiaqing li
  • Non-executive Directors, Strategy Committee Members
  • --
  • kunhong ceng
  • Independent Non-Executive Director, Audit Committee Members, Nomination Committee Members, Remuneration Committee Members
  • 300.00K
  • jian yu
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members, Nomination Committee Members
  • 300.00K
  • lihua li
  • Independent Non-Executive Director, Remuneration Committee Chairman, Chairman of the Nomination Committee, Audit Committee Members
  • 300.00K
  • kexin yang
  • Chairman of the Supervisory Board
  • 1.54M
  • shu feng
  • Non-employee Representative Supervisor
  • --
  • lan zhang
  • Employee Representative Supervisor
  • 830.00K
  • hua yang
  • Chief Scientific Officer
  • --
  • chengzong li
  • Chief Financial Officer, Board Secretary
  • --
  • luojun yan
  • Authorized Representative, Company Secretary
  • --
Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme CRO
CRO
Intraday-2.25%